Literature DB >> 15139868

Economic analysis of costs and consequences of the treatment of drug misuse: 2-year outcome data from the National Treatment Outcome Research Study (NTORS).

Christine Godfrey1, Duncan Stewart, Michael Gossop.   

Abstract

AIMS: Some economic costs and consequences of drug misuse and treatment were investigated among clients recruited to the National Treatment Outcome Research Study (NTORS).
DESIGN: This was a longitudinal prospective cohort design comprising 549 clients recruited from 54 residential and community treatment programmes: data were collected from interviews conducted at treatment intake, at 1 year and at 2-year follow-ups. MEASUREMENTS: Treatment costs included index and other drug treatments. Costs were estimated for use of health and social care services, criminal activity and the use of criminal justice resources. Costs were based upon self-reported data collected by structured face-to-face interviews combined with unit cost estimates taken from a variety of sources.
FINDINGS: Addiction treatment was costed at pound 2.9 million in the 2 years prior to index treatment, and a further pound 4.4 million in the subsequent 2 years. Economic benefits were largely accounted for by reduced crime and victim costs of crime. Crime costs fell by pound 16.1 million during the first year, and by pound 11.3 million during the second year. Health-care costs were relatively small but approximately doubled during the course of the study. The ratio of consequences to net treatment investment varied from 18 : 1 to 9.5 : 1, depending on assumptions. This is likely to be a conservative estimate of the benefit-cost ratio because many potential benefits were not estimated.
CONCLUSIONS: The data showed clear economic benefits to treating drug misusers in England.

Entities:  

Mesh:

Year:  2004        PMID: 15139868     DOI: 10.1111/j.1360-0443.2004.00752.x

Source DB:  PubMed          Journal:  Addiction        ISSN: 0965-2140            Impact factor:   6.526


  17 in total

1.  Substance use, education, employment, and criminal activity outcomes of adolescents in outpatient chemical dependency programs.

Authors:  Ana I Balsa; Jenny F Homer; Michael T French; Constance M Weisner
Journal:  J Behav Health Serv Res       Date:  2007-12-07       Impact factor: 1.505

Review 2.  Novel approaches to the treatment of cocaine addiction.

Authors:  Mehmet Sofuoglu; Thomas R Kosten
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

Review 3.  Opioid use disorder.

Authors:  John Strang; Nora D Volkow; Louisa Degenhardt; Matthew Hickman; Kimberly Johnson; George F Koob; Brandon D L Marshall; Mark Tyndall; Sharon L Walsh
Journal:  Nat Rev Dis Primers       Date:  2020-01-09       Impact factor: 52.329

4.  The Edinburgh Addiction Cohort: recruitment and follow-up of a primary care based sample of injection drug users and non drug-injecting controls.

Authors:  John Macleod; Lorraine Copeland; Matthew Hickman; James McKenzie; Jo Kimber; Daniela De Angelis; James R Robertson
Journal:  BMC Public Health       Date:  2010-02-26       Impact factor: 3.295

5.  Interim versus standard methadone treatment: a benefit-cost analysis.

Authors:  Robert P Schwartz; Pierre K Alexandre; Sharon M Kelly; Kevin E O'Grady; Jan Gryczynski; Jerome H Jaffe
Journal:  J Subst Abuse Treat       Date:  2013-10-14

Review 6.  Economic evaluation of interventions to treat opiate dependence : a review of the evidence.

Authors:  Christopher M Doran
Journal:  Pharmacoeconomics       Date:  2008       Impact factor: 4.981

7.  The size, burden and cost of disorders of the brain in the UK.

Authors:  Naomi A Fineberg; Peter M Haddad; Lewis Carpenter; Brenda Gannon; Rachel Sharpe; Allan H Young; Eileen Joyce; James Rowe; David Wellsted; David J Nutt; Barbara J Sahakian
Journal:  J Psychopharmacol       Date:  2013-07-24       Impact factor: 4.153

8.  Changes in somatic disease incidents during opioid maintenance treatment: results from a Norwegian cohort study.

Authors:  Ivar Skeie; Mette Brekke; Michael Gossop; Morten Lindbaek; Even Reinertsen; Magne Thoresen; Helge Waal
Journal:  BMJ Open       Date:  2011-08-06       Impact factor: 2.692

9.  A Comparison of Substance Use Patterns Among Lifetime Heroin-Injecting Individuals By Racial Groups.

Authors:  Tabitha E H Moses; Jamey J Lister; Mark K Greenwald
Journal:  Addict Res Theory       Date:  2019-06-30

10.  Using a pragmatically adapted, low-cost contingency management intervention to promote heroin abstinence in individuals undergoing treatment for heroin use disorder in UK drug services (PRAISE): a cluster randomised trial.

Authors:  Nicola Metrebian; Tim Weaver; Kimberley Goldsmith; Stephen Pilling; Jennifer Hellier; Andrew Pickles; James Shearer; Sarah Byford; Luke Mitcheson; Prun Bijral; Nadine Bogdan; Owen Bowden-Jones; Edward Day; John Dunn; Anthony Glasper; Emily Finch; Sam Forshall; Shabana Akhtar; Jalpa Bajaria; Carmel Bennett; Elizabeth Bishop; Vikki Charles; Clare Davey; Roopal Desai; Claire Goodfellow; Farjana Haque; Nicholas Little; Hortencia McKechnie; Franziska Mosler; Jo Morris; Julian Mutz; Ruth Pauli; Dilkushi Poovendran; Elizabeth Phillips; John Strang
Journal:  BMJ Open       Date:  2021-07-01       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.